±¹¿Ü ÀǾàÇ° GMP °¡À̵å¶óÀÎ µ¿Çâ ¸ðÀ½ÁýÀÌ ¹ß°£µÈ´Ù.
½ÄÇ°ÀǾàÇ°¾ÈÀüû(ûÀå ³ë¿¬È«) ½ÄÇ°ÀǾàÇ°¾ÈÀüÆò°¡¿øÀº ±¹³» ±ÔÁ¤¿¡ ´ëÇÑ ±¹Á¦Á¶È ±â¹ÝÀ» ¸¶·ÃÇÏ°í ÀǾàÇ° ÇؿܼöÃâ¾÷ü¿¡°Ô ±¹¿Ü µ¿Çâ¿¡ ´ëÇÑ Á¤º¸Á¦°øÀ» À§ÇØ ±¹¿Ü ÀǾàÇ° GMP °¡À̵å¶óÀÎ µ¿Çâ ¸ðÀ½ÁýÀ» ¹ß°£ÇÑ´Ù°í ¹àÇû´Ù.
À̹ø °¡À̵å¶óÀÎÀº 2010³â 7¿ùºÎÅÍ 1³â µ¿¾È FDA(Food and Drug Administration, ¹Ì±¹ ½ÄÇ°ÀǾ౹), EU(European Union, À¯·´¿¬ÇÕ), EMA(European Medicines Agency, À¯·´ÀǾàǰû), WHO(World Health Organization, ¼¼°èº¸°Ç±â±¸), ICH(International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, ÀǾàÇ° ±¹Á¦Çù·Â Á¶ÈȸÀÇ µîÀÇ GMP °¡À̵å¶óÀÎ °³Á¤·¹ß°£ »çÇ×À» Á¶»ç·ºÐ¼®ÇÑ °ÍÀÌ´Ù.
ÀÌ °¡À̵å¶óÀÎÀº ¡ã±¹¿Ü ÀǾàÇ° GMP °¡À̵å¶óÀÎ ºñ±³ ¹× ±¸¼º ¡ãWHO Annex 4 '¹«±Õ ÀǾàÇ° GMP’ ÃÊ¾È ¹ß°£ ¡ãEMA ICH Q11 °¡À̵å¶óÀÎ ¹ß°£ ¡ãFDA °øÁ¤ ¹ë¸®µ¥ÀÌ¼Ç °¡ÀÌ´ø½º ¹ß°£ µîÀ» ´ã¾Ò´Ù.
½Ä¾àûÀº À̹ø¿¡ ¸¶·ÃÇÑ µ¿ÇâÁýÀÌ ±¹³» GMP °ü·Ã ¾÷¹« Á¾»çÀڵ鿡°Ô ¸Å¿ì À¯¿ëÇÑ ÀÚ·á·Î È°¿ëµÉ »Ó ¾Æ´Ï¶ó, ±¹¹Îµé¿¡°Ô ¿ì¼öÇÑ Ç°ÁúÀÇ ÀǾàÇ°ÀÌ Á¦°øµÉ ¼ö ÀÖ´Â Á¦¾à »ê¾÷ °æÀï·Â °È¿¡ µµ¿òÀ» ÁÙ °ÍÀ¸·Î ±â´ëÇß´Ù.